1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Patient demographics and cancer type
Total Clinical Response Persistent Disease Patients and age (y) No. of patients 49 38 11 Age (mean) (yr) 63 (SD, 13) 61 (SD, 13) 68 (SD, 7) Sex No. of men 29 24 5 No. of women 20 14 6 Lesion location Cervical 2 2 0 Thoracic 27 20 7 Lumbar 16 13 3 Sacral 4 3 1 Metastatic source Lung 12 9 3 RCC 9 8 1 Breast 5 3 2 Prostate 4 4 0 Thyroid 4 4 0 Melanoma 3 3 0 Other 12 7 5
Note:—RCC indicates renal cell carcinoma.